Search Results - "Sodal, G"

Refine Results
  1. 1

    Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation by BERGAN, S, RUGSTAD, H. E, BENTDAL, Ø, SØDAL, G, HARTMANN, A, LEIVESTAD, T, STOKKE, O

    Published in Transplantation (15-08-1998)
    “…Azathioprine (AZA) is widely used in organ transplantation. Common practice is to adjust dose according to body weight only, despite documented pharmacokinetic…”
    Get full text
    Journal Article
  2. 2

    Possibilities for therapeutic drug monitoring of azathioprine : 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells by BERGAN, S, RUGSTAD, H. E, KLEMETSDAL, B, GIVERHAUG, T, BENTDAL, Ø, SØDAL, G, HARTMANN, A, AARBAKKE, J, STOKKE, O

    Published in Therapeutic drug monitoring (01-06-1997)
    “…The objectives of this study were to establish monitoring of azathioprine (AZA) treatment in renal allograft recipients by red blood cell (RBC) 6-thioguanine…”
    Get full text
    Journal Article
  3. 3

    Patterns of azathioprine metabolites in neutrophils, lymphocytes, reticulocytes, and erythrocytes : Relevance to toxicity and Monitoring in recipients of renal allografts by BERGAN, S, BENTDAL, Ø, SØDAL, G, BRUN, A, RUGSTAD, H. E, STOKKE, O

    Published in Therapeutic drug monitoring (01-10-1997)
    “…Monitoring of azathioprine (AZA) therapy by the measurement of 6-thioguanine nucleotides (6-TGN) concentrations in red blood cells (RBC) may improve safety and…”
    Get full text
    Conference Proceeding Journal Article
  4. 4

    Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients by Reisaeter, A V, Leivestad, T, Albrechtsen, D, Holdaas, H, Hartmann, A, Sødal, G, Flatmark, A, Fauchald, P

    Published in Transplantation (15-08-1995)
    “…Patients with preformed antibodies against HLA molecules accumulate on renal transplant waiting lists and have inferior graft survival compared with…”
    Get more information
    Journal Article
  5. 5

    Morphological studies of baseline needle biopsies from living donor kidneys: Light microscopic, immunohistochemical and ultrastructural findings by SUND, STÅLE, REISÆTER, ANNA V., SCOTT, HELGE, FAUCHALD, PER, BENTDAL, ØYSTEIN, SØDAL, GUNNAR, HOVIG, TORSTEIN

    “…Fifty‐seven consecutive living donors (31 women and 26 men aged 20.7–72.3 years, mean 50.6 years) were subjected to needle biopsy during nephrectomy,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Autonomous hyperparathyroidism in X-linked hypophosphataemia by Knudtzon, J, Halse, J, Monn, E, Nesland, A, Nordal, K P, Paus, P, Seip, M, Sund, S, Sødal, G

    Published in Clinical endocrinology (Oxford) (01-02-1995)
    “…Four patients with familial hypophosphataemic rickets developed significant hypercalcaemia which persisted after discontinuation of vitamin D therapy. They had…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Cadaveric organ donation in Scandinavia, 1992 by Gäbel, H, Ahonen, J, Södal, G, Lamm, L

    Published in Transplantation proceedings (01-06-1994)
    “…In countries with active organ transplant programs and wide acceptance criteria for transplant recipients, such as the four Scandinavian countries, the need…”
    Get more information
    Journal Article
  11. 11

    Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients by Kovarik, J M, Rawlings, E, Sweny, P, Fernando, O, Moore, R, Griffin, P J, Fauchald, P, Albrechtsen, D, Sodal, G, Nordal, K, Amlot, P L

    Published in Transplant international (1996)
    “…SDZ CHI 621 is a murine-human chimeric monoclonal antibody (mAb) to the interleukin-2 (IL-2) receptor (CD25) intended for prophylactic immunosuppression…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20